HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
soluflazine
nucleoside transport inhibitor; analog of mioflazine
Also Known As:
R 64719; R-64719; Soluflazine
Networked:
3
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Piperazines: 26
soluflazine: 3
Experts
1.
Biermans, Maria
: 1 article (01/2012)
2.
Hoffmann, Vincent Lh
: 1 article (01/2012)
3.
Maes, Sabine S
: 1 article (01/2012)
4.
Meert, Theo F
: 1 article (01/2012)
5.
Pype, Stefan
: 1 article (01/2012)
Related Diseases
1.
Hypoxia (Hypoxemia)
02/01/1993 - "
During severe N2-induced hypoxia, soluflazine significantly delayed hypoxic depolarization.
"
03/06/1989 - "
Soluflazine, administered topically or systemically, failed to enhance adenosine release and did not consistently alter the hypoxia/ischemia-evoked releases of inosine, hypoxanthine and xanthine.
"
2.
Ischemia
03/06/1989 - "
Soluflazine, administered topically or systemically, failed to enhance adenosine release and did not consistently alter the hypoxia/ischemia-evoked releases of inosine, hypoxanthine and xanthine.
"
3.
Hyperalgesia
01/01/2012 - "
Draflazine, dipyridamole, dilazep, lidoflazine, soluflazine, and KF24345 showed efficacy in the CFA thermal hyperalgesia model.
"
Related Drugs and Biologics
1.
Xanthine
2.
Hypoxanthine
3.
Lidoflazine
4.
Inosine
5.
Dipyridamole (Persantine)
6.
Dilazep
7.
Adenosine (Adenocard)
8.
3- (1- (6,7- diethoxy- 2- morpholinoquinazolin- 4- yl)piperidin- 4- yl)- 1,6- dimethyl- 2,4- (1H,3H)- quinazolinedione
9.
draflazine